Millions in need of HIV services will continue to be left out

July 1, 2014

Millions of people in need would benefit from HIV services in developing countries that are moving towards universal health coverage if these services were run more efficiently and integrated better into their health systems.

According to a study published in the Bulletin of the World Health Organization today, scaling up HIV services can achieve substantially lower unit-costs per patient, while integrating these services with other health-care services, such as for tuberculosis, can achieve better value for money than stand-alone services.

The study, by authors from the London School of Hygiene and Tropical Medicine and UNAIDS, is important because it points the way forward – not only for HIV services where US$ 19 billion was invested globally in 2012 – but for all services for chronic conditions, such as heart disease, cancer, diabetes and hypertension.

"HIV is one field where there seems to be a scientific consensus not only about what works but also about the most efficient ways to delivery health care," said Jeremy Lauer, a health economist in the department of Health Systems Governance and Financing at the World Health Organization (WHO).

"Economic evaluation of other health programmes also shows strong evidence from an economic, programmatic and ethical perspective to support comprehensive delivery models – ones that cover the complete spectrum of prevention, detection, treatment and care," he said.

"When you have comprehensive care for managing like HIV/AIDS – better prevention means less treatment, and early detection and effective treatment lead to better health outcomes for the patients," Lauer said.

In 2011, WHO's Member States set themselves the goal of developing their health financing systems as a stepping stone to . WHO is working with countries to review, develop and implement health financing strategies that could help them to move closer towards that goal.

In the field of HIV, progress has been made in making prevention and treatment services more widely available in low and middle-income countries. In the early 2000s, fewer than 50 000 people in sub-Saharan Africa were on antiretroviral treatment, but by the end of 2012 an estimated 9.7 million people in low and middle-income countries were receiving it.

Still, that covers only 34% of the 28.6 million people who are eligible for antiretroviral treatment, according to 2013 WHO guidelines.

The World Health Organization is currently revising its cost-effectiveness estimates for 20 diseases, risk factors and causes of injury, including in the field of HIV infection. The resulting review will serve as an evidence base for WHO guidance to countries on the path to universal health coverage.

The new study, by a team of researchers based in London and Geneva, which precedes the WHO review, analyzes 82 economic evaluation studies of HIV services in 35 low and middle-income countries.

It is the first comprehensive review of the technical efficiency and potential cost savings that can be achieved in low and middle-income countries in the six programme areas of the Joint United Nations Programme on HIV/AIDS (UNAIDS):

1. antiretroviral therapy and counselling and testing;

2. targeting at-risk populations (sex workers, men who have sex with men and people who inject drugs);

3. condom distribution and social marketing;

4. voluntary medical male circumcision;

5. programmes to prevent HIV infection in children and keep their mothers alive;

6. behaviour-change communications targeted at young adults and the general population.

For example, the authors found that the cost of treatment with antiretroviral drugs per patient and the cost of HIV prevention for key populations declines dramatically as the numbers of people reached increased.

"We found that the HIV services that reached high volumes of patients had much lower costs than those serving far fewer patients, but the likelihood of loss to follow-up – when these patient volumes are high – can be greater and is a key concern," said co-author Anna Vassall, a senior lecturer in economics at the London School of Hygiene and Tropical Medicine. "It's also important that increases in efficiency, by providing services in larger facilities, do not lead to increased payments for patients trying to access those services."

The authors found that the integration of HIV services with other services may be an important way to improve efficiency. For example, the study found that integrating tuberculosis and HIV services in low-income countries increased the impact of both programme areas, while at the same time optimizing the use of the scarce funds and clinical staff-time.

Finally, the study highlights the potential efficiency gains that can be made by improving the organization of support for the delivery of HIV services, pointing to a recent study in India, where these support costs – which are not included in service costs – can reach up to a third of the total cost of the HIV programmes themselves.

"More action and research is needed to help HIV programmes identify the best ways to improve efficiency, while at the same time ensuring that core HIV services delivered are of a high quality," Vassall said. ..

Explore further: Refugees and internally displaced persons should have equitable access to HIV treatment

Related Stories

Refugees and internally displaced persons should have equitable access to HIV treatment

June 10, 2014
"Given recent evidence and the moral, legal, and public health arguments, refugees and internally displaced persons situated in stable settings should have equitable access to HIV treatment and supportive services", argue ...

Aging with HIV and AIDS: A growing social issue

June 25, 2014
As the first people with HIV grow old, a new study from St. Michael's Hospital questions whether the health care system and other government policies are prepared to meet their complex medical and social needs.

Integrating mental health care into HIV care

May 21, 2013
The integration of mental health interventions into HIV prevention and treatment platforms can reduce the opportunity costs of care and improve treatment outcomes, argues a new Policy Forum article published in this week's ...

Lowering toxicity of new HIV drugs predicted to improve life expectancy

June 25, 2014
While bringing new drugs to market is important for increasing life expectancy in younger people with HIV, lowering the toxicity of those drugs may have an even greater health impact on all HIV patients, a University of Pittsburgh ...

In Africa, STI testing could boost HIV prevention

May 28, 2014
To maximize HIV prevention efforts in South Africa and perhaps the broader region, public health officials should consider testing for other sexually transmitted infections when they test for HIV, according to a new paper ...

Herpes virus infection drives HIV infection among non-injecting drug users in New York

June 28, 2014
HIV and its transmission has long been associated with injecting drug use, where hypodermic syringes are used to administer illicit drugs. Now, a newly reported study by researchers affiliated with New York University's Center ...

Recommended for you

Paris spotlight on latest in AIDS science

July 21, 2017
Some 6,000 HIV experts gather in Paris from Sunday to report advances in AIDS science as fading hopes of finding a cure push research into new fields.

Scientists elicit broadly neutralizing antibodies to HIV in calves

July 20, 2017
Scientists supported by the National Institutes of Health have achieved a significant step forward, eliciting broadly neutralizing antibodies (bNAbs) to HIV by immunizing calves. The findings offer insights for HIV vaccine ...

Heart toxin reveals new insights into HIV-1 integration in T cell genome

July 20, 2017
Human immunodeficiency virus (HIV)-1 may have evolved to integrate its genetic material into certain immune-cell-activating genes in humans, according to new research published in PLOS Pathogens.

Scientists capture first high-resolution image of key HIV protein transitional state

July 13, 2017
A new, three-dimensional snapshot of HIV demonstrates the radical structural transformations that enable the virus to recognize and infect host cells, according to a new study led by scientists at The Scripps Research Institute ...

Barrier to autoimmune disease may open door to HIV, study suggests

July 11, 2017
Researchers from the University of Colorado School of Medicine have discovered that a process that protects the body from autoimmune disease also prevents the immune system from generating antibodies that can neutralize the ...

Team tests best delivery mode for potential HIV vaccine

June 20, 2017
For decades, HIV has successfully evaded all efforts to create an effective vaccine but researchers at The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology (LJI) are steadily inching ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.